A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian Cysts

• Status: Not yet recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the effectiveness of (norethisterone acetate) in the treatment of spontaneously occurring simple ovarian cyst detected by ultrasonography compared with expectant management.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Norethindrone; Norethindrone Acetate

Criteria

Inclusion Criteria:

1. women at age 24-49 years old

2. women with simple cyst.( with none of the following: solid parts, papillary formations, peritoneal masses, intraabdominal lymph node enlargement or ascites ) .(13)

3. from 5 to10cm in diameter.

4. functioning cyst.( defined as largest dimension between 2-8 cm in diameter, unilateral, uniloculated, thin-walled, anechogenic and has distal acoustic enhancement )

Exclusion Criteria:

1. premenarche

2. postmenopause

3. current user of Norethisterone acetate.

4. those having contraindication from Norethisterone use.

5. gynecologic malignancy